Call for Evidence on the Clinical Use of Human Germline Genome Editing

The International Commission on the Clinical Use of Human Germline Genome Editing seeks information in response to its call for evidence.

See the link below.

Responses are due by 27 September. Information submitted to the Commission will inform its deliberations as it develops a framework identifying scientific, medical, and ethical requirements to consider as part of a potential pathway from research to clinical use — if society concludes that heritable human genome editing applications are acceptable. The Commission’s report is expected to be released in 2020. Several question in the call invite broad input, while others are more technical in nature. You are encouraged to address those questions most relevant to your particular area(s) of expertise. When appropriate, providing citations and/or links to evidence in support of your responses is greatly appreciated.

https://forms.royalsociety.org/s/4X3D5/